-
Fund Dashboard
- Holdings
Franklin Biotechnology Discovery Fund
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
AMGN Amgen Inc. | 59.84 mm | 186.91 k shares | 6.67 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 54.61 mm | 114.73 k shares | 6.09 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 52.15 mm | 62.22 k shares | 5.82 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 43.48 mm | 489.54 k shares | 4.85 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies, Inc. | 30.10 mm | 355.21 k shares | 3.36 | Common equity | Long | USA |
ARGX argenx SE | 26.08 mm | 44.49 k shares | 2.91 | Common equity | Long | Netherlands |
INSM Insmed Incorporated | 25.50 mm | 379.04 k shares | 2.84 | Common equity | Long | USA |
Merus NV
|
24.95 mm | 499.70 k shares | 2.78 | Common equity | Long | Netherlands |
AstraZeneca plc
|
23.94 mm | 336.41 k shares | 2.67 | Common equity | Long | UK |
Jazz Pharmaceuticals plc
|
23.81 mm | 216.36 k shares | 2.65 | Common equity | Long | Ireland |
BIIB Biogen Inc. | 22.51 mm | 129.34 k shares | 2.51 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 22.35 mm | 210.14 k shares | 2.49 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 20.04 mm | 166.63 k shares | 2.23 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 19.19 mm | 480.61 k shares | 2.14 | Common equity | Long | USA |
Institutional Fiduciary Trust - Money Market Portfolio | 19.04 mm | 19.04 mm shares | 2.12 | Short-term investment vehicle | Long | USA |
ASND Ascendis Pharma A/S | 16.82 mm | 136.97 k shares | 1.88 | Common equity | Long | Denmark |
SPRY ARS Pharmaceuticals, Inc. | 14.09 mm | 956.99 k shares | 1.57 | Common equity | Long | USA |
BNTC Benitec Biopharma Inc. | 13.63 mm | 1.30 mm shares | 1.52 | Common equity | Long | USA |
APLT Applied Therapeutics, Inc. | 13.58 mm | 1.54 mm shares | 1.51 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 12.81 mm | 228.93 k shares | 1.43 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics, Inc. | 12.68 mm | 1.53 mm shares | 1.41 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 12.42 mm | 843.95 k shares | 1.39 | Common equity | Long | USA |
EYPT EyePoint Pharmaceuticals, Inc. | 12.19 mm | 1.04 mm shares | 1.36 | Common equity | Long | USA |
Institutional Fiduciary Trust Money Market Portfolio | 11.96 mm | 11.96 mm shares | 1.33 | Short-term investment vehicle | Long | USA |
PRAX Praxis Precision Medicines, Inc. | 11.51 mm | 164.40 k shares | 1.28 | Common equity | Long | USA |
ILMN Illumina, Inc. | 11.49 mm | 79.69 k shares | 1.28 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 11.09 mm | 41.60 k shares | 1.24 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 10.53 mm | 83.58 k shares | 1.17 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 10.47 mm | 357.71 k shares | 1.17 | Common equity | Long | USA |
ACHV Achieve Life Sciences, Inc. | 10.21 mm | 2.18 mm shares | 1.14 | Common equity | Long | USA |
AVTR Avantor, Inc. | 8.59 mm | 383.93 k shares | 0.96 | Common equity | Long | USA |
MLYS Mineralys Therapeutics, Inc. | 8.53 mm | 637.83 k shares | 0.95 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals, Inc. | 8.28 mm | 215.19 k shares | 0.92 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 8.09 mm | 155.54 k shares | 0.90 | Common equity | Long | USA |
Zealand Pharma A/S, Class A
|
8.05 mm | 69.70 k shares | 0.90 | Common equity | Long | Denmark |
DYN Dyne Therapeutics, Inc. | 7.76 mm | 268.93 k shares | 0.87 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals, Inc. | 7.67 mm | 406.55 k shares | 0.86 | Common equity | Long | USA |
CGEM Cullinan Oncology, Inc. | 7.53 mm | 483.95 k shares | 0.84 | Common equity | Long | USA |
CNTA Centessa Pharmaceuticals plc | 7.36 mm | 489.23 k shares | 0.82 | Common equity | Long | UK |
SYRE Spyre Therapeutics, Inc. | 7.16 mm | 220.00 k shares | 0.80 | Common equity | Long | USA |
GH Guardant Health, Inc. | 7.08 mm | 323.37 k shares | 0.79 | Common equity | Long | USA |
ORKA Oruka Therapeutics Inc. | 7.00 mm | 249.96 k shares | 0.78 | Common equity | Long | USA |
CGON CG Oncology, Inc. Common stock | 6.93 mm | 195.10 k shares | 0.77 | Common equity | Long | USA |
RVNC Revance Therapeutics, Inc. | 6.64 mm | 1.13 mm shares | 0.74 | Common equity | Long | USA |
AURA Aura Biosciences, Inc. | 6.47 mm | 619.99 k shares | 0.72 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 5.85 mm | 100.75 k shares | 0.65 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc. | 5.82 mm | 141.43 k shares | 0.65 | Common equity | Long | Cayman Islands |
Jade Biosciences GmbH | 5.00 mm | 5.00 mm principal | 0.56 | Debt | Long | Germany |
NUVL Nuvalent, Inc. | 4.98 mm | 56.25 k shares | 0.56 | Common equity | Long | USA |
ABVX Abivax SA American Depositary Shares | 4.96 mm | 480.30 k shares | 0.55 | Common equity | Long | France |
CTNM Contineum Therapeutics, Inc. Class A Common Stock | 4.95 mm | 295.06 k shares | 0.55 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 4.82 mm | 289.58 k shares | 0.54 | Common equity | Long | USA |
KURA Kura Oncology, Inc. | 4.71 mm | 281.88 k shares | 0.53 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 4.69 mm | 8.58 k shares | 0.52 | Common equity | Long | USA |
ADVM Adverum Biotechnologies, Inc. | 4.56 mm | 624.74 k shares | 0.51 | Common equity | Long | USA |
AQST Aquestive Therapeutics, Inc. | 4.55 mm | 828.90 k shares | 0.51 | Common equity | Long | USA |
JSPR Jasper Therapeutics, Inc. | 4.50 mm | 212.24 k shares | 0.50 | Common equity | Long | USA |
OCUL Ocular Therapeutix, Inc. | 4.32 mm | 410.10 k shares | 0.48 | Common equity | Long | USA |
uniQure NV
|
4.14 mm | 723.82 k shares | 0.46 | Common equity | Long | Netherlands |
Cogent Biosciences, Inc., Series B
|
3.91 mm | 340.45 k shares | 0.44 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc. | 3.84 mm | 93.36 k shares | 0.43 | Common equity | Long | Canada |
MBX MBX Biosciences, Inc. Common Stock | 3.77 mm | 164.50 k shares | 0.42 | Common equity | Long | USA |
CTNM Contineum Therapeutics, Inc. Class A Common Stock | 3.64 mm | 216.97 k shares | 0.41 | Common equity | Long | USA |
Benitec Biopharma, Inc.
|
3.27 mm | 310.88 k shares | 0.36 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 3.23 mm | 63.32 k shares | 0.36 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals, Inc. | 3.17 mm | 338.30 k shares | 0.35 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 2.87 mm | 510.00 k shares | 0.32 | Common equity | Long | USA |
CNTA Centessa Pharmaceuticals plc | 2.85 mm | 189.74 k shares | 0.32 | Common equity | Long | UK |
ANAB AnaptysBio, Inc. | 2.79 mm | 128.98 k shares | 0.31 | Common equity | Long | USA |
CNTX Context Therapeutics Inc. | 2.70 mm | 1.24 mm shares | 0.30 | Common equity | Long | USA |
CAMP4 Therapeutics Corporation | 2.48 mm | 233.70 k shares | 0.28 | Common equity | Long | USA |
NGNE Neurogene Inc. | 2.43 mm | 55.20 k shares | 0.27 | Common equity | Long | USA |
Engene Holdings, Inc.
|
2.41 mm | 272.36 k shares | 0.27 | Common equity | Long | Canada |
Sartorius AG | 2.38 mm | 9.20 k shares | 0.27 | Preferred equity | Long | Germany |
ABOS Acumen Pharmaceuticals, Inc. | 2.38 mm | 826.40 k shares | 0.27 | Common equity | Long | USA |
PLRX Pliant Therapeutics, Inc. | 2.24 mm | 158.90 k shares | 0.25 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 2.10 mm | 41.20 k shares | 0.23 | Common equity | Long | USA |
Sartorius Stedim Biotech
|
2.03 mm | 10.10 k shares | 0.23 | Common equity | Long | France |
Lycia LLC, Series C
|
1.97 mm | 859.37 k shares | 0.22 | Common equity | Long | Japan |
KRRO Korro Bio, Inc. | 1.94 mm | 33.80 k shares | 0.22 | Common equity | Long | USA |
Candid, Inc., Series B
|
1.82 mm | 1.52 mm shares | 0.20 | Common equity | Long | USA |
SYRE Spyre Therapeutics, Inc. | 1.75 mm | 53.80 k shares | 0.20 | Common equity | Long | USA |
RLMD Relmada Therapeutics, Inc. | 1.59 mm | 456.40 k shares | 0.18 | Common equity | Long | USA |
ARTV Artiva Biotherapeutics, Inc. Common Stock | 1.52 mm | 149.67 k shares | 0.17 | Common equity | Long | USA |
ALEC Alector, Inc. | 1.49 mm | 303.35 k shares | 0.17 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc. | 1.43 mm | 34.63 k shares | 0.16 | Common equity | Long | Cayman Islands |
ENGN enGene Holdings Inc. | 1.26 mm | 141.90 k shares | 0.14 | Common equity | Long | Canada |
HLVX HilleVax, Inc. | 1.25 mm | 691.36 k shares | 0.14 | Common equity | Long | USA |
KYTX Kyverna Therapeutics, Inc. | 1.17 mm | 244.90 k shares | 0.13 | Common equity | Long | USA |
Achieve Life Sciences, Inc. | 1.04 mm | 2.18 mm shares | 0.12 | Long | USA | |
ANRO Alto Neuroscience, Inc. | 1.03 mm | 263.90 k shares | 0.11 | Common equity | Long | USA |
Alto Neuroscience, Inc.
|
642.12 k | 165.07 k shares | 0.07 | Common equity | Long | USA |
IN8bio, Inc.
|
503.62 k | 2.09 mm shares | 0.06 | Common equity | Long | USA |
Artiva Biotherapeutics, Inc.
|
438.10 k | 43.21 k shares | 0.05 | Common equity | Long | USA |
Carmot Therapeutics, Inc.
|
412.08 k | 83.10 k shares | 0.05 | Common equity | Long | USA |
IN8bio, Inc. | 369.98 k | 2.09 mm shares | 0.04 | Long | USA | |
NUVB Nuvation Bio Inc. | 9.60 k | 115.27 k shares | 0.00 | Long | USA | |
Sanofi SA, Escrow Account
|
0 | 2.33 mm shares | 0.00 | Common equity | Long | Colombia |